Clinical trial
Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial
NCT02219880 is registered in ClinicalTrials.gov with University of Melbourne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial
- Lead sponsor
- University of Melbourne
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 13, 2015
- Completion date
- May 31, 2018
- Enrollment
- 178 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.